A Biden spokeswoman confirmed the former president finished several weeks of radiation therapy treatment Monday.

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today presents on the positive interim efficacy data from its ongoing ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma U.S. Inc. (Head of Commercial: Mike Petroutsas, "Astellas") today announced final ...

It is not unusual for advanced prostate cancer to become resistant to treatment. Of these resistant cases, some progress to a ...

A novel combination of already approved drugs has shown a 40.3% reduction in death risk from advanced recurring prostate cancer in a long-term trial.

Scientists have found a new method that could treat patients with advanced prostate cancer. Experts at The Institute of Cancer Research, London, found that a two-pronged method could help treat as ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.